2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Kidney Acute Graft Injury

54.31 - Optimizing serum creatinine monitoring for the rapid detection of complications in the early post-kidney transplant period

Presenter: Nicholas, Cross, Christchurch, New Zealand
Authors: Cross N., Macaskill P., Hayen A., Webster A., Wong G., O'Connell P., Chapman J., Nankivell B., Craig J.

OPTIMIZING SERUM CREATININE MONITORING FOR THE RAPID DETECTION OF COMPLICATIONS IN THE EARLY POST-KIDNEY TRANSPLANT PERIOD

KIDNEY - ACUTE GRAFT INJURY

N.B. Cross1, P. Macaskill2, A. Hayen1, A. Webster3, G. Wong4, P.J. O'connell5, J.R. Chapman6, B. Nankivell7, J.C. Craig4
1School Of Public Health, University of Sydney, Sydney/AUSTRALIA, 2, University of Sydney, Sydney/AUSTRALIA, 3School Of Public Health, University of Sydney, Sydney/NSW/AUSTRALIA, 4Centre For Kidney Research, The Children's Hospital at Westmead, Westmead/AUSTRALIA, 5Centre Of Transplant And Renal Research, Westmead Hospital, Westmead/NSW/AUSTRALIA, 6Renal Unit, Westmead Hospital, Westmead/AUSTRALIA, 7, Westmead Hospital, Sydney/AUSTRALIA

Body: Introduction
After kidney transplantation, serum creatinine is monitored routinely. Rising serum creatinine, relative to expected values, is used an indicator of complications, but the optimal method for determining expected values in the first post-transplant month is unknown.

Methods
Using retrospective data, we compared five methods for defining individual patients’ expected creatinine values - daily group mean (mean creatinine by postoperative day in patients without complications), nadir (lowest prior creatinine), delta (previous day’s creatinine) and two methods using a multivariate prediction model which adjusts daily expected values for patient, donor and transplant characteristics known at time of transplant (day zero predictions) and a more complex model that also included individuals’ prior observed creatinine values (daily predictions). For each method, we estimated area under the receiver operating characteristic curve (AUC) for percentage rise in creatinine relative to expected creatinine for detection of biopsy confirmed, clinically diagnosed complications in the first posttransplant month. We also assessed when complications would have been detected for the day zero predictions and daily predictions methods, relative to when complications were detected clinically.

Results
Among 157 included patients, 56 had complications in the first month after transplantation. Group mean (AUC 0.86 95%CI 0.82-0.91), nadir (AUC 0.68, 95%CI 0.61-0.75) and delta methods (AUC 0.79, 95%CI 0.73-0.85) did not perform as well as day zero (AUC 0.90, 95%CI 0.87-0.94) or daily predictions (AUC 0.94, 95%CI 0.93-0.96). The prediction methods detected complications at least one day earlier than was achieved clinically in 80% of patients.

Conclusions
Rises in creatinine relative to predicted creatinine, based on a mixed model, provided better test performance than other methods studied.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada